NSE - Delayed Quote INR

Aurobindo Pharma Limited (AUROPHARMA.NS)

1,191.70
+3.50
+(0.29%)
At close: May 23 at 3:30:00 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 79.79B
Earnings 8.46B

Q1'24

Q2'24

Q3'24

Q4'24

0
20B
40B
60B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,140.00
1,476.89 Average
1,191.70 Current
1,930.00 High

Earnings Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7--2526
Avg. Estimate 17.79063.0375.85
Low Estimate 17.5059.969.05
High Estimate 18.1070.283.2
Year Ago EPS 17.05--56.5363.03

Revenue Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1512326
Avg. Estimate 82.85B86.01B315.48B347.8B
Low Estimate 80.17B86.01B313.58B335.47B
High Estimate 85.72B86.01B318.97B371B
Year Ago Sales 75.8B75.67B290.02B315.48B
Sales Growth (year/est) 9.30%13.66%8.78%10.24%

Earnings History

Currency in INR 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 15.3816.5816.2915.54
EPS Actual 17.0515.691414.56
Difference 1.66-0.89-2.29-0.98
Surprise % 10.82%-5.39%-14.05%-6.30%

EPS Trend

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 17.79063.0375.85
7 Days Ago 17.45063.2775.97
30 Days Ago 17.77063.3975.98
60 Days Ago 17.45063.5576.6
90 Days Ago 17.74063.5276.58

EPS Revisions

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1----1
Up Last 30 Days 1----1
Down Last 7 Days ----11
Down Last 30 Days ----32

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
AUROPHARMA.NS 4.33%--11.50%20.33%
S&P 500 12.65%2.47%7.33%14.11%

Related Tickers